SFE Intravascular Imaging Platform
Chronic Total Occlusion (CTO) Guidance, Embolic Stroke Source Detection, General Intravascular Diagnostics
Key Facts
About VerAvanti
VerAvanti is a private, pre-revenue medical device innovator founded in 2018 and based in San Diego. The company is developing a disruptive intravascular imaging platform using its patented Scanning Fiber Endoscope (SFE) technology, which offers forward-looking, real-time, full-color video from a 1mm catheter. This technology targets significant gaps in current side-view imaging (IVUS, OCT) and angiography, particularly for visualizing Chronic Total Occlusions (CTOs) and embolic sources. VerAvanti's device has the potential to improve procedural success rates, patient safety through a single-use design, and hospital operational efficiency.
View full company profile